Journal profile · Gastroenterology & Hepatology
Alimentary Pharmacology & Therapeutics
ISSN 0269-2813 · eISSN 1365-2036 · Wiley-Blackwell Publishing Ltd · ENGLAND · Semimonthly · Founded 1987
Alimentary Pharmacology & Therapeutics: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 6.72; hybrid open access; APC about USD 5,250; review about 7 days (submission to acceptance, publisher); community-reported acceptance: fairly easy; 632 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Alimentary Pharmacology & Therapeutics is published by Wiley-Blackwell Publishing Ltd and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Inflammatory Bowel Disease, Helicobacter pylori-related gastroenterology studies and Gastrointestinal motility and disorders, together about 31% of its articles. Its main subfields are Epidemiology. (generated from OpenAlex topic counts and CAS ranking data)
Alimentary Pharmacology & Therapeutics is an international journal of gastroenterology and hepatology.The journal accepts systematic reviews, meta-analyses, randomised controlled trials and original papers concerned with Gastroenterology and Hepatology.AP&T is particularly interested in therapies and diagnostics, including all aspects of translation from bench to bedside: identification of novel therapeutic targets, epidemiology, clinical trials, drug safety and meta-analyses.
From the journal's Aims & Scope
Research area (LetPub): Gastroenterology & Hepatology
Editorial board by country: none in mainland China; most named Hong Kong, China 6, United Kingdom 6, United States 3, Australia 2, Singapore 2 (22 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Inflammatory Bowel DiseaseBiochemistry, Genetics and Molecular Biology11.2%
- Helicobacter pylori-related gastroenterology studiesMedicine10.8%
- Gastrointestinal motility and disordersMedicine9%
- Gastroesophageal reflux and treatmentsMedicine9%
- Liver Disease Diagnosis and TreatmentMedicine8.8%
- Microscopic ColitisMedicine7%
- Hepatitis C virus researchMedicine5.4%
- Liver Disease and TransplantationMedicine5.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Pharmacology & Pharmacy | Zone 1 |
| Minor | Gastroenterology & Hepatology | Zone 2 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Gastroenterology & Hepatology | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Pharmacology & Pharmacy | Zone 1 |
| Minor | Gastroenterology & Hepatology | Zone 2 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbaseCAB AbstractsCurrent ContentsPublisher website
Other: EBSCO
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 6.72LetPub ·
- Impact factor (publisher) 2025
- 6.8Publisher website ·
- Impact factor (publisher) 2024
- 6.7Publisher website ·
- CiteScore 2026-06
- 14LetPub ·
- CiteScore (publisher)
- 14Publisher website ·
- CiteScore (publisher) 2025
- 14Publisher website ·
- SJR 2026-06
- 3.01LetPub ·
- SJR (publisher)
- 2.89Publisher website ·
- SNIP 2026-06
- 1.92LetPub ·
- h-index
- 159LetPub ·
- h-index
- 248OpenAlex ·
- i10-index
- 7,654OpenAlex ·
- 2-year mean citedness
- 3.82OpenAlex ·
- Self-citation rate
- 8.8%LetPub ·
- Share of gold OA articles
- 47.44%LetPub ·
Volume
- Articles per year
- 239LetPub ·
- Articles per year (publisher) 2025
- 578Publisher website ·
- Downloads per year (publisher) 2025
- 1,431,922Publisher website ·
Articles by year OpenAlex count · 14,449 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 500 | 299 | 516 |
| 2025 | 632 | 514 | 2,001 |
| 2024 | 643 | 524 | 4,258 |
| 2023 | 511 | 433 | 4,197 |
| 2022 | 593 | 289 | 7,319 |
| 2021 | 535 | 305 | 7,930 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref
Not usableThis publisher's "received" date is mostly when the revised manuscript arrived (40% of articles were "accepted" within 3 days), so it cannot measure review time
Figures by source
- Average review time (community reports)
- 3–6 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Acceptance rate (publisher)
- 17%Publisher website ·
- Acceptance rate (publisher) 2025
- 17%Publisher website ·
- Submission to first decision
- 2 daysPublisher website ·
- Submission to first decision 2025
- 2 daysPublisher website ·
- Submission to acceptance 2025
- 7 daysPublisher website ·
- Acceptance to publication
- 49 daysPublisher website ·
- Acceptance to publication 2025
- 14 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 5,250 / EUR 4,400 / GBP 3,480 | — | — | |
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≥ 3
Article types accepted2
- original articles• Original ArticlesLength not stated
- systematic reviews• Systematic ReviewsLength not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, Open access, Peer review, Plagiarism, Preprints, Trial registration / reporting guidelines
- AI use Artificial Intelligence Generated Content
Artificial Intelligence Generated Content (AIGC) tools—such as ChatGPT and others based on large language models (LLMs)—cannot be considered capable of initiating an original piece of research without direction by human authors. They also cannot be accountable for a published work or for research design, which is a generally held requirement of authorship (as discussed in the previous section), no…
Source ↗Publisher website ·- Authorship Authorship
Please refer to the journal’s Authorship policy in the Editorial Policies and Ethical Considerations section for details on author listing eligibility.
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest Statement
Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the ‘Conflict of Interest’ section in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.
Source ↗Publisher website ·- Data availability Data Sharing and Data Accessibility
AP&T expects that data supporting the results in the paper will be archived in an appropriate public repository. Authors are required to provide a data availability statement to describe the availability or the absence of shared data. When data have been shared, authors are required to include in their data availability statement a link to the repository they have used, and to cite the data they h…
Source ↗Publisher website ·- Publication ethics Publication Ethics
Member of COPE Model summary
This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley's Top 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.
Source ↗Publisher website ·- Open access Open Access
Open Access is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With Open Access, the author, the author's funding agency, or the author's institution pays a fee (Article Publication Charge, or APC) to ensure that the article is made …
Source ↗Publisher website ·- Peer review Peer Review and Acceptance
Single-blind peer review Model summary
The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. The journal operates a single-blind peer-review process using a body of over 5,500 expert peer reviewers; papers are normally reviewed by two or more reviewers plus one or more Editors. Invited Editorials and Letters to the Editors about past papers in AP&T are not usu…
Source ↗Publisher website ·- Plagiarism Plagiarism and falsification
Uses iThenticate CrossCheck Model summary
The Journal may scrutinise all papers for evidence of plagiarism and falsified data using specialised software. Plagiarism can comprise the following:
Source ↗Publisher website ·- Preprints Preprint Policy
Preprints accepted Model summary
Alimentary Pharmacology & Therapeutics will consider for review articles previously available as preprints. Authors may also post the submitted version of a manuscript to a preprint server at any time. Authors are requested to update any pre-publication versions with a link to the final published article.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the abstract. If the trial is not registered, or was registered retrospectivel…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Semimonthly
- Founded
- 1987
- ISSN
- 0269-2813
- Electronic ISSN
- 1365-2036
- Latest issue on the website
- Volume 64, Issue 7 (October 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Alimentary Pharmacology & Therapeutics
What CAS zone is Alimentary Pharmacology & Therapeutics in?
In the 2025 upgraded edition of the CAS Journal Ranking, Alimentary Pharmacology & Therapeutics is in Zone 1 of Medicine, and in Zone 1 of the minor category Pharmacology & Pharmacy / Gastroenterology & Hepatology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Alimentary Pharmacology & Therapeutics?
The latest impact factor listed by LetPub is 6.72; CiteScore 14, h-index 248.
How long does peer review take at Alimentary Pharmacology & Therapeutics?
The publisher reports about 7 days (submission to acceptance); authors report an average review time of 3–6 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 17% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Alimentary Pharmacology & Therapeutics?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 3. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Alimentary Pharmacology & Therapeutics based?
Of the 22 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Hong Kong, China (6), United Kingdom (6) and United States (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Alimentary Pharmacology & Therapeutics?
According to LetPub and DOAJ records, Alimentary Pharmacology & Therapeutics is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed, Embase, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Alimentary Pharmacology & Therapeutics open access, and what is the APC?
Alimentary Pharmacology & Therapeutics is a hybrid journal. For open-access publication: APC about USD 5,250.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .